SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx
Clinical trial NCT06219980 · RECRUITING
Trial details
- NCT number
- NCT06219980
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-07
- Primary completion
- 2025-12-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.